DOSSIER · 13F-HR · Q2 2026

Catalio Capital Management, LP

$532M in tracked AUM across 39 positions as of Q2 2026.

CC
CIK 0001958125 · last filed Jun 30, 2026
Total AUM
$532M
as of Q2 2026
Holdings
39
positions
Whale Score
63
63
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

Catalio Capital Management, LP filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
AVLN
AVALYN PHARMACEUTICALS INC
$55M1.7M10.4%
02
JNJ
JOHNSON & JOHNSON
$35M139K6.6%
03
GILD
GILEAD SCIENCES INC
$34M269K6.4%
04
BBIO
BRIDGEBIO PHARMA INC
$34M455K6.4%
05
SNDX
SYNDAX PHARMACEUTICALS INC
$27M1.2M5.0%
06
DFTX
DEFINIUM THERAPEUTICS INC
$26M563K5.0%
07
BMY
BRISTOL-MYERS SQUIBB CO
$24M413K4.5%
08
PBLS
PARABILIS MEDICINES INC
$23M824K4.2%
09
NTRA
NATERA INC
$22M82K4.2%
10
INCY
INCYTE CORP
$22M192K4.1%

Filing history

2026Q2Jun 30
$532M 11.2%
39 positionsView →
2026Q1Mar 31
$479M 15.4%
41 positionsView →
2025Q4Dec 31
$566M 4.6%
45 positionsView →
2025Q3Sep 30
$541M 13.4%
38 positionsView →
2025Q2Jun 30
$477M 107.4%
40 positionsLocked
2025Q1Mar 31
$230M 49.7%
24 positionsLocked
2024Q4Dec 31
$457M
33 positionsLocked